{"database": "lobbying", "table": "lobbying_activities", "rows": [[3044446, "82ef916b-1266-4094-80ca-bb9985cadde2", "3T", "STONINGTON GLOBAL", 401105189, "SORRENTO THERAPEUTICS, INC.", 2023, "third_quarter", "PHA", "Promoting non-opioid pain management alternatives.", "Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, null, 0, 1, "2023-10-03T14:11:36-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3044446"], "units": {}, "query_ms": 1.8960459856316447, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}